Richard K. Prins - Jun 4, 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Jun 4, 2021
Transactions value $
-$23,051
Form type
4
Date filed
6/8/2021, 08:59 PM
Previous filing
May 14, 2021
Next filing
Nov 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $82.2K +5K +12.77% $16.43 44.2K Jun 4, 2021 Direct
transaction AMPH Common Stock Sale -$93.9K -5K -11.32% $18.77 39.2K Jun 4, 2021 Direct F1
transaction AMPH Common Stock Options Exercise $82.2K +5K +12.77% $16.43 44.2K Jun 7, 2021 Direct
transaction AMPH Common Stock Sale -$93.5K -5K -11.32% $18.70 39.2K Jun 7, 2021 Direct
transaction AMPH Common Stock Award $0 +6.02K +15.37% $0.00 45.2K Jun 7, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -5K -50% $0.00 5K Jun 4, 2021 Common Stock 5K $16.43 Direct F3
transaction AMPH Stock Option (right to buy) Options Exercise $0 -5K -100% $0.00* 0 Jun 7, 2021 Common Stock 5K $16.43 Direct F3
transaction AMPH Stock Option (right to buy) Award $0 +17.2K $0.00 17.2K Jun 7, 2021 Common Stock 17.2K $19.52 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.77 to $18.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 7, 2022.
F3 Shares subject to the option are fully vested and immediately exercisable.
F4 All of the shares subject to the option vest on June 7, 2022.